News & Press Releases
Filter by:
Mintz Announces Partnership with Lineal’s Amplify Technology Suite
November 19, 2024
Mintz has partnered with Lineal, a leader in legal technology and data review solutions to assist with client services delivery. The collaboration brings Lineal’s Amplify Suite—an advanced RelativityOne integration—into Mintz’s practice to enhance early data assessment (EDA), streamline modern data review, and manage strategic decision calls.
Mintz Advises Charlesbank Capital Partners on Strategic Investment with IMPLAN Group
November 18, 2024
Mintz advised Charlesbank Capital Partners (“Charlesbank”), a middle-market private equity firm with more than $22 billion in total assets, on a strategic investment with IMPLAN Group LLC (“IMPLAN”), a leading provider of economic impact data and analytical software.
Mintz Recovers Over $400M for Institutional Investor Clients in 2024
November 14, 2024
Mintz's Institutional Investor Class Action Recovery Practice has recovered $400 million for institutional investor clients in 2024 and expects projects for recoveries exceeding $500 million by year end.
Mintz Serves as Expert Contributor to University of Oxford Report on Climate Regulations
November 13, 2024
Mintz is one of two US law firms invited by Oxford University to serve as an expert pro bono contributor to its Climate Policy Monitor, an annual report on global climate regulations which launched today. Including a granular survey of 30 major countries’ net zero implementation (G20+), the research gives the most detailed view yet of how economic rules align—or not—to climate goals.
Mintz represented the US Department of Energy’s Loan Programs Office in its conditional commitment for a loan guarantee of up to $1.44 billion to Montana Renewables, LLC. Montana Renewables is an unrestricted subsidiary of Calumet (NASDAQ: CLMT). The deal team was led by Project Development & Finance Chair Ayaz Shaikh, Paul Dickerson, Kris Kirkwood, and Lyndon Plothow.
Mintz Associate Adam Falconi has been appointed Chair of Life Sciences for Licensing Executives Society (USA & Canada), Inc. (LES).